Genopathy
Gene-Disorder Association · Article
Gene
ELOC
Elongin C
Disorder
Renal Cell Carcinoma
First reported 1998
Supporting publications 2
Key publication · gene–disorder pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation.Proceedings of the National Academy of Sciences of the United States of America · 1998
Key publication · disorder Polycythaemia vera; coexisting with malignant tumours (particularly hypernephroma).Acta medica Scandinavica · 1950
Manually curated
Association Review

In brief

The association between ELOC (Elongin C) and Renal Cell Carcinoma is reported, with clinical genetic testing available.

Sources 1
Clinical variants 0
Symptoms 1
Compounds 0
Trials 0
Publications 2
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
ELOC

The gene

1 source summary

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Renal Cell Carcinoma

The disorder

8 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Literature

Reading

2 publications

Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.

Request access
06
Provenance

References & sources

6 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access